Gene: TMED6
Official Full Name: transmembrane p24 trafficking protein 6provided by HGNC
Gene Summary: Predicted to be involved in Golgi organization; endoplasmic reticulum to Golgi vesicle-mediated transport; and intracellular protein transport. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23991 | TMED6 Knockout cell line (HCT 116) | Human | TMED6 | 1:2~1:4 | Negative | Online Inquiry |
KO23992 | TMED6 Knockout cell line (HEK293) | Human | TMED6 | 1:3~1:6 | Negative | Online Inquiry |
TMED6 Gene Knockout Cell Lines are innovative, genetically engineered cell lines designed to facilitate the study of the TMED6 gene’s biological functions and its implications in various physiological and pathological processes. The TMED6 protein, a member of the transmembrane emp24 protein transport family, is involved in intracellular transport and the maintenance of cellular homeostasis. By knocking out the TMED6 gene, researchers can observe the resultant phenotypic changes and elucidate the mechanisms through which TMED6 contributes to cellular functions, making these cell lines invaluable tools in genetic research.
These knockout cell lines operate through the use of CRISPR-Cas9 technology, which allows for precise gene editing to create loss-of-function mutations within the TMED6 gene. This targeted approach makes it possible to investigate the functional consequences of gene depletion and assess the impact on cellular pathways, signaling mechanisms, and disease models. The ease of use and versatility of these cell lines opens avenues for significant advancements in research surrounding cancer biology, neurodegenerative diseases, and metabolic disorders where TMED6 has been implicated.
The scientific importance of TMED6 Gene Knockout Cell Lines extends to their applications in drug discovery and biomarker identification. By providing a reliable model for studying the role of TMED6, researchers can potentially uncover novel therapeutic targets and explore the efficacy of specific treatments, leading to meaningful clinical applications.
Compared to alternative gene-editing models, TMED6 Gene Knockout Cell Lines present the unique advantage of being ready-to-use and validated for performance. They eliminate the time-consuming processes of gene editing and selection, enabling researchers to focus on experimentation and analysis right away. Furthermore, our commitment to quality ensures that these cell lines are rigorously tested for consistency and reliability.
For researchers and clinicians seeking to deepen their understanding of cellular biology and disease mechanisms, TMED6 Gene Knockout Cell Lines represent an essential resource. Our company's expertise in producing precision biological products ensures that you receive high-quality tools tailored for your research needs, empowering advancements in science and healthcare.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.